Hims & Hers is promoting Chief Commercial Officer Mike Chi to operating chief. Chi will succeed Nader Kabbani as chief operating officer on Nov. 2, the digital healthcare company said. Kabbani plans ...

A number of stocks jumped in the afternoon session after news of a new government prescription drug policy and a landmark ...

The great thing about finding these innovative companies is that you don't have to be first line to buy shares. You could ...

But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look. Everyone has their own methods for finding great value opportunities, but our ...

Brands like Hims & Hers and Planet Fitness are known for offering wellness products to customers, but seeing how they treat ...

This article was reviewed by Felix Gussone, MD. If you’ve been feeling a bit more couch potato than go-getter lately, ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. You’ve got a lot of choices when it comes to weight loss ...

Novo took the active ingredient of Ozempic, semaglutide, and rebranded it as Wegovy to be used specifically for weight loss.

Biologics are drugs that require a living organism to manufacture, instead of simply being compounded in a lab. Read on to ...

"Influencer marketing is no longer about reach, it's about resonance and ROI," said Yehuda Neuman, SVP of Influencer Marketing at PartnerCentric. "Our research shows consumers remember influencer ...

Tidal Investments, LLC is the adviser for all YieldMax® ETFs. THE FUND, TRUST, AND ADVISER ARE NOT AFFILIATED WITH ANY UNDERLYING REFERENCE ASSET. Risk Disclosures (applicable to all YieldMax ETFs ...

Hims & Hers Health (HIMS) has seen its stock climb steadily, jumping 39% in the past month. This upward trend is catching attention, with investors curious about what is fueling the company’s ongoing ...